References
- Pass H. I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 1993; 85: 443–456
- Dolphin D. Photomedicine and photodynamic therapy. Can. J. Chem. 1994; 72: 1005–1013
- Levy J. G. Photodynamic therapy. TIB Tech. 1995; 13: 14–18
- Schieweck K., Capraro H.-G., Isele U., van Hoogevest P., Ochsner M., Maurer T., Batt E. CGP 55 847, liposome-delivered zinc(II)-phthalocyanine as a phototherapeutic agent for tumours. SPIE Proc. 1994; 2078: 107–118
- Isele U., van Hoogevest P., Hilfiker R., Capraro H. G., Schieweck K., Leuenberger H. Large-scale production of liposomes containing monomeric zinc phthalocyanine by controlled dilution of organic solvents. J. Pharm. Sci. 1994; 83: 1608–1616
- Isele U., Schieweck K., Kessler R., van Hoogevest P., Capraro H.-G. Pharmacokinetics and body distribution of liposomal zinc phthalocyanine in tumor-bearing mice: influence of aggregation state, particle size, and composition. J. Pharm. Sci. 1995; 84: 166–173
- Love W. G., Duk S., Biolo R., Jori G., Taylor P. W. Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration. Photochem. Photobiol. 1996; 63: 656–661
- Warloe T., Peng Q., Heyerdahl H., Moan J., Steen H. B., Giercksky K.-E. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/ EDTA for basal cell carcinoma. SPIE Proc. 1995; 2371: 226–235
- Heinritz H., Benzel W., Sroka R., Iro H. Photodynamic therapy of superficial skin tumors following local application of delta-aminolevulinic acid. Adv. Otorhinolaryngol. 1995; 49: 48–52
- Boehnecke W.-H., König K., Kaufmann R., Scheffold W., Prümmer O., Sterry W. Photodynamic therapy in psoriasis: suppression of cytokme production in vitro and recording of fluorescence modification during treatment in vivo. Arch. Dennatd. Res. 1994; 286: 300–303
- Levy J. G., Jones C. A., Pilson L. A. The preclini-cal and clinical development of Photofrin and benzoporphyrin derivative: a reflection on opportunities and challenges. J. Photochem. Photobiol. B: Biol. 1995; 30: 79–82
- Camisa C. Psoriasis. Blackwell Scientific Publications, Boston 1994
- Valduga G., Reddi E., Jori G. Spectroscopic studies on Zn(II)-phthalocyanine in homogeneous and microheterogeneous systems. J. Inorg. Biochem. 1987; 29: 59–65
- Spikes J. D. Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumors. Photochem. Photobiol. 1986; 43: 691–699
- Barry B. W. Mode of action of penetration enhancers in human skin. J. Controlled Release 1987; 6: 85–97
- Turunen T. M., Urtti A. Penetration enhancers in transdermal drug delivery. Acta Pharm. Fenn. 1992; 101: 3–10
- Santus G. C., Baker R. W. Transdermal enhancer patent literature. J. Controlled Release 1993; 25: 1–20
- Handbook of Pharmaceutical Excipents, 2nd ed., A. Wade, P. J. Weller. The Pharmaceutical Press, London 1994
- Lasch J., Wohlrab W. Liposome-bound cortisol: a new approach to cutaneous therapy. Biomed. Biochim. Acta. 1986; 45: 1295–1299
- du Plessis J., Egbaria K., Weiner N. Influence of forniulation factors on the deposition of liposomal components into the different strata of the skin. J. Soc. Cosmet. Chem. 1992; 43: 93–100
- Nastruzzi C., Esposito E., Menegatti E., Walde P. Use and stability of liposomes in dermatological preparations. J. Appl. Cosmetol. 1993; 11: 77–91
- Eur. Patent Appl., 38416 A2. Desinfektionsmittel-formulierungen mit spezifischem Wirkungsmechanismus, Oct. 28, 1981 (to Intermedicat)
- Ochsner M. Light scattering of human skin: a comparison between zinc(ii)-phthalocyanine and Photofrim II. J. Photochem. Photobiol. B: Biol. 1996; 32: 3–9
- Reddi E., Zhou C., Biolo R., Menegaldo E., Jori G. Liposome- or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Br. J. Cancer 1990; 61: 407–411
- Milanesi C., Zhou C., Biolo R., Jori G. Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosenstised tumour necrosis. Br. J. Cancer 1990; 61: 846–850
- Love W. G., Havenaar E. C., Lowe P. J., Taylor P. W. Uptake of zinc(II)-phthalocyanine by HepG2 cells expressing the LDL receptor: studies with the liposomal formulation CGP 55 847. SPIE Proc. 1994; 2078: 381–388
- Bartsch W., Sponer G., Dietmann K., Fuchs G. Acute toxicity of various solvents in the mouse and rat. Artzneim. Forsch. 1976; 26: 1581–1583
- Becci P. J., Gephart L. A., Koschier F. J., Johnson W. D., Burnette L. W. Subchronic feeding study in beagle dogs of N-methylpyrrolidone. J. Appl. Toxicol. 1983; 3: 83–86
- Ansell J. M., Fowler J. A. The acute oral toxicity and primary ocular and dermal irritation of selected N-alkyl-2-pyrrolidones. Fd. Chem. Toxic. 1988; 26: 475–479
- Elias P. M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 1983; 80: 44s–49s
- Imokawa G., Akasaki S., Hattori M., Yoshizuka N. Selective recovery of deranged water-holding properties by stratum corneum lipids. J. Invest. Dermatol 1986; 87: 758–764